Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …
Facility updates from Aptar Pharma, Granules-Omnichem and Pii, plus a fill/finish problem for Lpath and seaweed-based pharma capsules. Aptar Pharma …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

